Table 1.
Socio-demographic, clinical and para-clinical characteristics of patients and annual incidence of tuberculosis.
| Parameters | Number (%) | p-value | TB -n (%) | TB + n (%) | IR (% year) | IR by group (% year) |
|---|---|---|---|---|---|---|
| Age (year)* | ||||||
| 18 - 24 | 62 (09.15) | 0.03 | 51(0.91) | 11 (10.58) | 17.74 | 15.74 |
| 25 - 34 | 284 (41.94) | 239 (41.72) | 45 (43.27) | 15.84 | ||
| 35 - 44 | 226 (33.38) | 192 (33.51) | 34 (2.70) | 15.05 | ||
| 45 - 54 | 81 (11.97) | 69 (12.05) | 12 (11.53) | 14.82 | 13.33 | |
| 55 - 64 | 23 (3.9) | 21(03.66) | 2 (1.92) | 8.69 | ||
| ≥ 65 | 1 (0.17) | 1(0.17) | 0 (0.0) | 0.0 | ||
| Sex | ||||||
| Male | 192 (28.36) | 0.35 | 156(27.23) | 36(34.62) | 18.75 | 18.75 |
| Female | 485 (71.64) | 417(72.77) | 68 (65.38) | 14.02 | 14.02 | |
| CD4 rate** | ||||||
| ˂ 50 | 60 (08.86) | 0.03 | 53(09.25) | 7 (6.73) | 11.66 | 14.39 |
| 50 - 199 | 165 (24.37) | 132(23.03) | 33(31.73) | 0.2 | ||
| 200 - 349 | 310 (45.79) | 273(47.65) | 37(35.58) | 11.94 | ||
| ≥ 350 | 142 (20.98) | 115 (20.07) | 27(25.96) | 19.01 | 19.01 | |
| Clinical stage by WHO *** | ||||||
| I | 320 (47.34) | 0.02 | 314 (54.80) | 6 (5.77) | 1.87 | 02.82 |
| II | 213 (31.46) | 204(35.61) | 9(8.65) | 4.22 | ||
| III | 128 (18.93) | 50 (08.72) | 77 (75.00) | 60.15 | 61.80 | |
| IV | 16 (2.37) | 5 (0.87) | 12 (10.58) | 75.00 | ||
| ARV treatment | ||||||
| Yes | 618 (91.28) | 0.03 | 537(93.71) | 81 (77.88) | 13.10 | 13.10 |
| No | 59 (08.72) | 36 (06.28) | 23 (22.12) | 38.99 | 38.99 | |
| Observance**** | ||||||
| Good | 657 (97.05) | 0.004 | 557(97.21) | 100 (96.14) | 15.22 | 15.22 |
| Medium | 13 (1.92) | 11(01.92) | 2 (01.93) | 15.38 | 23.53 | |
| Poor | 7(1.03) | 5 (0.87) | 2 (01.93) | 28.57 | ||
| Functional capacity ***** | ||||||
| Active | 604 (89.21) | 0.04 | 566(98.78) | 38(36.54) | 6.30 | 6.30 |
| Slimming | 70 (10.34) | 4(0.69) | 66 (63.46) | 94.28 | 90.42 | |
| Bedridden | 3 (0.45) | 3(0.53) | 0 (0.0) | 0.0 | ||
* = p-value for 18–44 years and ≥ 45 years.
** = p-value for CD4˂350 and CD4˃350/mm3.
*** = p-value for clinical stages group I and II and clinical stages group III and IV of WHO.
**** = p-value for observance group good and observance group medium and poor.
***** = p-value for active group and slimming and bedridden groups.
IR= Incidence rate.